While President Donald Trump is betting on lower prescription drug prices, a number of payers reportedly have a less optimistic forecast for the future. According to a STAT report, a new survey by Cowen analysts suggests more than two dozen payers believe per-unit purchasing costs will see anywhere […]
Latest Stories
Study: Praluent Not Worth Price
New research published in the Annals of Internal Medicine suggests the price tag on Sanofi and Regeneron's cholesterol-lowering drug, Praluent, is not cost-effective despite a recent price decrease, pharmaphorum reports. The study, which was based on results from the ODYSSEY OUTCOMES trial, […]
Drugmakers Raise Prices to Start 2019
A number of pharmaceutical companies raised prices on hundreds of drugs to ring in the new year, according to a MarketWatch report. Allergan PLC is reportedly leading the increases with a roughly 10 percent hike on more than two dozen drugs. The drugmaker said it increased prices on 51 of its […]
- Previous Page
- 1
- …
- 605
- 606
- 607
